GSK buys COVID and flu vaccines from shrinking CureVac company

British drugmaker GSK on Wednesday bought out partner CureVac from its alliance to develop influenza vaccines and COVID-19, boosting its RNA informatics expertise and expanding the German biotech company’s financial capabilities.

Teile diesen Beitrag:

BELIEBTE BEITRÄGE
FOLGEN SIE UNS
Like uns auf Facebook
Folge uns auf Twitter
Abonniere unseren Kanal
Tick Tack
LIVEÜBERTRAGUNG